T-Track® CMV in vitro diagnostic ELISpot kit (IVD)
Diagnostic test for the measurement of CMV-specific cell-mediated immunity based on the ELISpot method combined with the T-activation® Technology.
- Sensitive and standardized ELISpot
- High clinical sensitivity
- Assessment of the functionality of a broad network of clinically-relevant CMV-specific effector cells (CD4+ and CD8+ T cells, NK and NKT-like cells)
- HLA antigen-independent application
- New: Low amount of patient blood sample required
- New: 24 hour sample storage time
- New: Delivered with the T-Track® CMV Calculator software
- CE-marked IVD in Europe
T-Track® ImmunoScan ELISpot kit
The T-Track® ImmunoScan assay is a test to evaluate the functionality of cell-mediated immunity in the course of a natural or induced immune modulation.
- Based on the T-Track® basic IFN-γ ELISpot assay combined with the T-activated® ImmunoScan Cocktail
- Measures the response of effector cells of adaptive and innate immunity (CD4+ and CD8+ T cells, NK and NKT-like cells)
- For research use only
T-Track® human IFN-γ HiSpecificityPRO ELISpot kit
The T-Track® ELISpot kit human IFN-γ HiSpecificityPRO is a highly standardized and sensitive ELISpot assay to analyze human IFN-γ-secreting cells.
- All-in-one ELISpot kit
- For comprehensive analysis of IFN-γ-secreting cells
- Highest specifictiy
- Low background
- Standardized read-out
- Available in 96-well solid and 12 x 8-well strip format
- For research use only
T-Track® human IFN-γ HiSpecificityPRO ELISpot plate
The T-Track® ELISpot plate human IFN-γ HiSpecificityPRO for individualized ELISpot assays.
- Ready-to-use precoated ELISpot plate
- For comprehensive analysis of IFN-γ-secreting cells
- Highest specifictiy
- Low background
- Standardized read-out
- Available in 96-well solid and 12 x 8-well strip format
T-activated® proteins and ImmunoScan cocktail
- Modified by Lophius´ T-activation® Technology
- Are actively processed by APC along the MHC class II and I (cross-presentation) pathways leading to a physiological and comprehensive stimulation
- Activate simultaneously clinically-relevant populations of effector cells, including CD4+ and CD8+ T cells as well as NK and NKT-like cells
- Lead to a robust and reliable stimulation of effector cells
- Applicable for many immunological assays such as ELISpot, FACS and ELISA